Cosmos Health (COSM) Capital Expenditures (2015 - 2026)
Cosmos Health's (COSM) quarterly Capital Expenditures came in at $63637.0 in Q2 2026, up 182.4% on a YoY basis from $22534.0 in Q2 2025, and up 458.27% quarter-over-quarter from $11399.0 in Q1 2026.
Analysis
Cosmos Health (COSM) Capital Expenditures (2015 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Capital Expenditures for 12 consecutive years, with $63637.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures rose 182.4% year-over-year to $63637.0; the trailing twelve-month figure through Jun 2026 stood at $95647.0 (down 71.56% YoY), and the FY2025 full-year result was $55675.0, down 86.68% from the prior year.
- Capital Expenditures improved to $63637.0 in Q2 2026 per COSM's latest filing, from $11399.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q2 2023 and bottomed at $4438.0 in Q1 2022.
- Historically, Capital Expenditures has averaged $107566.0 across 5 years, with a median of $26568.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures tumbled 98.9% in 2022, then surged 4414.92% in 2023.
- Over 5 years, Capital Expenditures stood at $37070.0 in 2022, then increased by 25.99% to $46705.0 in 2023, then jumped by 55.19% to $72482.0 in 2024, then plunged by 89.11% to $7895.0 in 2025, then surged by 706.04% to $63637.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $63637.0, $11399.0, and $7895.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 104.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 52.80 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -36.19 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 30.70 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 77.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -27.87 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 3.05 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 8.59 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 63,637.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,637.00 |
| Mar 31, 2026 | 11,399.00 |
| Dec 31, 2025 | 7,895.00 |
| Sep 30, 2025 | 12,716.00 |
| Jun 30, 2025 | 22,534.00 |
| Mar 31, 2025 | 12,530.00 |
| Dec 31, 2024 | 72,482.00 |
| Sep 30, 2024 | 228,767.00 |
| Jun 30, 2024 | 34,164.00 |
| Mar 31, 2024 | 82,662.00 |
| Dec 31, 2023 | 46,705.00 |
| Sep 30, 2023 | 16,557.00 |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 26,028.00 |
| Dec 31, 2022 | 37,070.00 |
| Sep 30, 2022 | 5,591.00 |
| Jun 30, 2022 | 27,108.00 |
| Mar 31, 2022 | 4,438.00 |
| Dec 31, 2021 | 59,640.00 |
| Sep 30, 2021 | 509,658.00 |